What does BR stand for?

Binary Restenosis

This definition appears very rarely and is found in the following Acronym Finder categories:

Science, medicine, engineering, etc.

Other Resources:

<< Previous	Abbreviation Database Surfer		Next >>
Beam Rifle (anime, Mobile Suit Gundam) Bedrest Bedroom Bellevue Reporter (community newspaper) Bend Radius (cable flexibility) Best Regards Bharat Rakshak Bible Review Bidirectional Ring Bills Receivable		Biological and Radiological Biological Research Birth Rate Bit Rate Bitte Rücksprache (German: Please Contact) Black Adder Black Reign (TNA iMPACT gaming wrestler) Blackburn Rovers Blackground Records (record label) Blade Rate

Samples in periodicals archive:

The use of paclitaxel-eluting stents also resulted in a significant reduction in binary restenosis after 13 months, which is the rate at which the artery re-narrows at least 50 per cent following implantation of the stent, and was the secondary efficacy endpoint of the trial.

Drug-eluting stents found to be superior in efficacy to bare metal ...

Endpoints included mortality, limb salvage, primary patency, angiographic binary restenosis (>50%), and clinically driven target-lesion re-intervention rates.

Drug-eluting stents save limbs in patients with peripheral vascular ...

Binary restenosis was 0%, and no stent thrombosis was observed.

Second-generation devices and a look at some alternatives

The primary endpoint of the study is binary restenosis at nine months, a measure of vessel renarrowing.

ABBOTT EVALUATES RX HERCULINK ELITE RENAL STENT

The primary objective at both sites was to evaluate the safety and efficacy of the FlexStent([R]) as measured by the absence of in-stent binary restenosis (patency) using duplex ultrasound (DUS) at 1, 6 and 12 month intervals.

Latest Clinical Experience with the FlexStent[R] Femoropopliteal Self ...

In 2005, the SIRTAX study, published in the NEJM, found statistically significant differences favoring the CYPHER(R) Stent compared with the Taxus stent across a variety of measures, including major cardiac adverse events (MACE), TLR, in-segment late loss and in-segment binary restenosis.

BIFURCATION LESIONS FARE BETTER WITH SIROLIMUS-ELUTING STENT

Data from one study showed that none of five animals treated with the polymer-coated stent exhibited binary restenosis, while eventually four of five uncoated-stent animals developed the problem.

Future stent designs, coatings may aid in improving outcomes

NEVO([TM]) also outperformed Taxus([R]) Liberte([R]) on a host of secondary endpoints, including stent thrombosis, target lesion revascularization, target vessel revascularization, major cardiovascular adverse events, and angiographic in-segment binary restenosis.

NEVO[TM] Sirolimus-Eluting Coronary Stent Associated with ...